Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives), Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Contraceptive Drugs and Devices – Choice to Conceive, Not Concede

Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries. For instance, contraceptive drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face advertising restrictions in India. Owing to this, contraceptives preference greatly various across countries. Statistics revealed by the United Nations in 2015, highlight this trends, with a particular contraceptive accounting for over 50% share across 45 countries considered in the study. Sterilization is a dominant contraceptive method in regions such as Asia, North America, and Latin America as per the study. Intra-uterine devices (IUDs), vaginal rings, injectables, implants, combined oral contraceptives, and patches are some of the more advanced contraceptive methods available in the market. Introduction of new male contraceptive products with high success rate are projected to shape the course of growth of the market in the near future.

Factors impacting the contraceptive drugs and devices market in different regions:

  • Implementation of the stringent two-child policy in China since 2016, is a major factor driving demand for contraceptives in the country
  • Societal stigma impacting the demand for contraceptives negatively in Asia and Africa
  • Government programs encouraging the use of selected contraceptives affecting the market for other products (Indian government provides incentives for sterilization and distributes free condoms, while the U.S. Affordable Care Act emphasizes on complete insurance coverage for long-acting reversible contraceptives (LARC)

The global contraceptive drugs and devices market was valued at US$ 18,273.2 million in 2015 and is expected to expand at a CAGR of 7.8% during the forecast period (2016 – 2024).

Figure 1. Global Contraceptive Drugs and Devices Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024

contraceptive drugs and devices market

Source: Coherent Market Insights Analysis (2016)

Favorable reimbursement scenario in the U.S. to propel uptake of contraceptives

Thousands of women are protesting against the new policies of President Trump on the Affordable Care Act (for products and services including reproductive health) which is likely to impact the affordability and accessibility of products to U.S. citizens. The State, however, announced insurance coverage of health and reproductive products to continue without any co-pays, co-insurance or deductibles. In addition to this, the new policy would also cover all medically essential abortion services for the U.S. population. This is a much anticipated relief for the general population in the U.S., where around 45% of all pregnancies reported are unintended (CDC, 2009-2013 study data).

Insurance coverage for devices also varies from state to state in the U.S. For instance, few states have low Medicaid reimbursement rates than the cost of the device, while few states provide reimbursement only to those women who have been prescribed such devices. For instance, in California, dispensing of injectable contraceptives is only allowed by clinics, while Alabama, Idaho, and South California do not cover emergency contraceptive pills as part of the Medicaid programs in their respective states. Many such limitations in Medicaid coverage creates disparity in demand for certain contraceptives across regions in the U.S. An endeavor to standardize the rule all over the country is expected to benefit the population at large.

High unmet need, especially in the African region

According to the United Nations (UN) study in 2015, the number of married and in-union women (15 years–49 years age group) using contraceptives is expected to reach 778 million by 2030, from a reported 758 million in 2015. Moreover, the study reflects a high unmet need at 22% (2015) in the African region, followed by Asia Pacific with 12.5% (2015). Also, there has been increase in usage of contraceptives among the sexually active women population in Nigeria from 23% in 2014 to 30% in 2015, post the Federal Government’s advocacy on usage of contraceptives among its women population, as per the report of the National Bureau of Statistics (NBS) in 2015.

Thus, market players such as Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Reckitt Benckiser Plc, Pfizer, Inc., Bayer AG, Cooper Surgical, Inc., and Allergan plc. should focus on the African market for potential revenue opportunities in the long run.

High preference for modern contraceptive methods in developed regions

As per results of a detailed study by the United Nation in 2015, 9 out of 10 married or in-union women opt for modern contraceptive methods. Use of IUD in the U.S. women population has resulted in decrease in the rate of unintended pregnancies from 51% (2006–2010) to 45% (2009–2013) as per the CDC’s National Survey of Family Growth. Furthermore, higher success rate and availability of reimbursement is encouraging women to opt for these methods over contraceptive pills. With increasing consumer awareness and rising accessibility to modern contraceptives methods, demand for these products is expected to increase in emerging economies such as India, China, and Brazil during the forecast period. Gynecologists and sexologists are recommending use of long-acting reversible contraceptives for couples who do not intend to have a child in near future, owing to their low side-effects and high effectiveness as compared to conventional contraceptives such as oral hormonal pills.

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid 60% of maternal deaths and 57% of child deaths worldwide, as opined by the World Health Organization (WHO) in 2014. Therefore, various family planning initiatives have been introduced across the globe be governmental and non-governmental agencies in order to create awareness about prevention of unplanned pregnancy.

Market Dynamics

Use of contraceptives is low in emerging economies especially in Africa, according to report ‘Trends in Contraceptive Use Worldwide 2015’, of the United Nations in 2015. Moreover, WHO estimates that around 225 million women in as of 2015, emerging economies who would like to delay their pregnancy are not using any contraception method. The impact of this is realized through the number of abortions carried out each year, with around 21.6 million unsafe abortions reported annually. Around 85% of these are reported in emerging economies in Africa and Asia, as per estimates of WHO (2016). Increasing awareness among the population through government initiatives and increasing accessibility to various contraceptive devices and drugs are expected to propel growth of contraceptive drugs and devices market in the near future.

The demand for advanced contraceptive options such as IUD, injectables, combined oral pills and diaphragms is observed to be high globally. This is owing to growing awareness among the populace, availability of reimbursement and growing demand for long term contraceptive methods.

Market Taxonomy

This report segments the global contraceptives drugs and devices market on the basis of product type and geography. On the basis of product type, the global contraceptives market is segmented into drug and devices. Drugs are further sub-segmented into oral pills, injectables, and topical contraceptives. The contraceptive devices segment is further sub-segmented into male contraceptives devices and female contraceptives devices. Mentioned below is the detailed segmentation. For comprehensive understanding of market dynamics, the global contraceptives drugs and devices market is analyzed across key geographies namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

  • This report provides in-depth analysis of the contraceptives drugs and devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global contraceptives drugs and devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Reckitt Benckiser Plc, Pfizer, Inc., Bayer AG, Mayer Laboratories, Inc., The Female Health Company, Cooper Surgical, Inc., Allergan plc, Cipla Limited, and Merck & Co. Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, market expansion, and marketing tactics
  • The global contraceptives market report caters to various stakeholders in this industry, including investors, drug and device manufacturers, distributors and suppliers for contraceptives drugs and devices, government organizations, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the contraceptives drugs and devices market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Contraceptives Drugs And Devices Market, By Product Type:
    • Oral Contraceptive Pills
    • Contraceptive Injectables
    • Topical Contraceptives
    • Male Contraceptive Devices
      • Condoms
    • Female Contraceptive Devices
      • Hormonal
      • Copper-T
      • Female Condoms
      • Contraceptive Diaphragms
      • Contraceptive Sponges
      • Contraceptive Vaginal Rings
      • Intrauterine Devices
      • Subdermal Contraceptive Implants
    • Contraceptive Drugs
    • Contraceptive Devices
  • Global Contraceptives Drugs And Devices Market, By Geography:
    • U.S.
      • Contraceptive Drugs
      • Contraceptive Devices
      • U.S. Contraceptives Drugs And Devices Market, By Product Type:
    • Canada
      • Contraceptive Drugs
      • Contraceptive Devices
      • Canada Contraceptives Drugs And Devices Market, By Product Type:
    • U.K.
      • Contraceptive Drugs
      • Contraceptive Devices
      • U.K. Contraceptives Drugs And Devices Market, By Product Type:
    • Germany
      • Contraceptive Drugs
      • Contraceptive Devices
      • Germany Contraceptives Drugs And Devices Market, By Product Type:
    • Italy
      • Contraceptive Drugs
      • Contraceptive Devices
      • Italy Contraceptives Drugs And Devices Market, By Product Type:
    • France
      • Contraceptive Drugs
      • Contraceptive Devices
      • France Contraceptives Drugs And Devices Market, By Product Type:
    • Spain
      • Contraceptive Drugs
      • Contraceptive Devices
      • Spain Contraceptives Drugs And Devices Market, By Product Type:
    • Russia
      • Contraceptive Drugs
      • Contraceptive Devices
      • Russia Contraceptives Drugs And Devices Market, By Product Type:
    • Rest of Europe
      • Contraceptive Drugs
      • Contraceptive Devices
      • Rest of Europe Contraceptives Drugs And Devices Market, By Product Type:
    • China
      • Contraceptive Drugs
      • Contraceptive Devices
      • China Contraceptives Drugs And Devices Market, By Product Type:
    • India
      • Contraceptive Drugs
      • Contraceptive Devices
      • India Contraceptives Drugs And Devices Market, By Product Type:
    • Japan
      • Contraceptive Drugs
      • Contraceptive Devices
      • Japan Contraceptives Drugs And Devices Market, By Product Type:
    • ASEAN
      • Contraceptive Drugs
      • Contraceptive Devices
      • ASEAN Contraceptives Drugs And Devices Market, By Product Type:
    • Australia
      • Contraceptive Drugs
      • Contraceptive Devices
      • Australia Contraceptives Drugs And Devices Market, By Product Type:
    • South Korea
      • Contraceptive Drugs
      • Contraceptive Devices
      • South Korea Contraceptives Drugs And Devices Market, By Product Type:
    • Rest of Asia Pacific (APAC)
      • Contraceptive Drugs
      • Contraceptive Devices
      • Rest of APAC Contraceptives Drugs And Devices Market, By Product Type:
    • Brazil
      • Contraceptive Drugs
      • Contraceptive Devices
      • Brazil Contraceptives Drugs And Devices Market, By Product Type:
    • Mexico
      • Contraceptive Drugs
      • Contraceptive Devices
      • Mexico Contraceptives Drugs And Devices Market, By Product Type:
    • Rest of Latin America
      • Contraceptive Drugs
      • Contraceptive Devices
      • Rest of Latin America Contraceptives Drugs And Devices Market, By Product Type:
    • GCC
      • Contraceptive Drugs
      • Contraceptive Devices
      • GCC Contraceptives Drugs And Devices Market, By Product Type:
    • Israel
      • Contraceptive Drugs
      • Contraceptive Devices
      • Israel Contraceptives Drugs And Devices Market, By Product Type:
    • Rest of Middle east
      • Contraceptive Drugs
      • Contraceptive Devices
      • Rest of Middle East Contraceptives Drugs And Devices Market, By Product Type:
    • North Africa
      • Contraceptive Drugs
      • Contraceptive Devices
      • North Africa Contraceptives Drugs And Devices Market, By Product Type:
    • Central Africa
      • Contraceptive Drugs
      • Contraceptive Devices
      • Central Africa Contraceptives Drugs And Devices Market, By Product Type:
    • South Africa
      • Contraceptive Drugs
      • Contraceptive Devices
      • South Africa Contraceptives Drugs And Devices Market, By Product Type:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
    • Future Plans
    • Teva Pharmaceutical Industries Ltd.*
    • Church & Dwight Co. Inc.
    • Reckitt Benckiser Plc
    • Pfizer, Inc.
    • Bayer AG
    • Mayer Laboratories, Inc.
    • The Female Health Company
    • Cooper Surgical, Inc.
    • Allergan Plc
    • Cipla Limited
    • Merck & Co. Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Product Type
      • Market Snippet By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Contraceptives Comparison
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
    • Industry Trend
    • Mergers and Acquisitions
    • Technology Overview
    • Promotion Initiatives
    • Pricing Analysis
  4. Global Contraceptive Drugs and Devices Market, By Product Type, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Drugs
      • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
        • Oral Contraceptive Pills
          • Introduction
          • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
        • Contraceptive Injectables
          • Introduction
          • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
        • Topical Contraceptives
          • Introduction
          • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Devices
      • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
        • Male Devices
          • Condoms
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
        • Female Devices
          • Condoms
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
          • Contraceptive Diaphragms
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
          • Contraceptive Sponges
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
          • Contraceptive Vaginal Rings
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
          • Intrauterine Devices
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
              • Hormonal IUD
              • Copper-T IUD
          • Subdermal Contraceptive Implants
            • Introduction
            • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  5. Global Contraceptive Drugs and Devices Market, By Geography, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, For Regions, 2014 - 2024
    • North America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
    • Europe
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Spain
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • China
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
    • Latin America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
    • Middle East
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
    • Africa
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
  6. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Church & Dwight Co. Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Pfizer, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bayer AG
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Mayer Laboratories, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • The Female Health Company
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Merck & Co. Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Allergan Plc
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cooper Surgical, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cipla Limited
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • HLL Lifecare
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 55 market data tables and 30 figures on "Contraceptive Drugs and Devices Market - Global forecast to 2024”.  

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.